Dr Amit Chakrabarti
Designation Scientist-F (Medical)
Divsion Toxicology & Industrial Hygiene, ROHC(E), Kolkata
Email amit[dot]chakrabarti[at]gov[dot]in
Contact 033-2367 4390/4955/3262 Ext. 108

Academic Qualifications

  • MD
  • DNB


  • Member, National Academy of Medical Sciences, India (M.N.A.M.S)
  • Member, International Brain Research Organization (I.B.R.O)
  • Member, Indian Pharmacological Society (I.P.S)
  • Member, Association of Physiologists and Pharmacologists of India (A.P.P.I)
  • Member, Association of Indian Humphrey Fellows
  • Member, International Harm Reduction Association (I.H.R.A)


  • NIDA International Forum Travel Award by National Institute on Drug Abuse (NIDA) to attend 2011 NIDA International Forum and 73rd Annual Meeting of the College on Problems of Drug Dependence (CPDD), Hollywood, Florida, USA – in 2011.   
  • NIDA International Forum Travel Award by National Institute on Drug Abuse (NIDA) to attend 2009 NIDA International Forum and 71st Annual Meeting of the College on Problems of Drug Dependence (CPDD), Reno, USA – in 2009.
  • INVEST / Clinical Trials Network (CTN) Drug Abuse Research Fellowship awarded by the National Institute on Drug Abuse (NIDA), NIH, USA at Division of Alcohol and Drug Abuse, McLean Hospital & Department of Psychiatry, Harvard Medical School, Boston, USA – October 2008 to September 2009.    
  • Hubert H. Humphrey Alumni Professional Development Grant awarded by US Department of State and the Institute of International Education, USA to attend 2007 National Institute on Drug Abuse (NIDA) International Forum and 69th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Quebec City, Canada – in 2007.   
  • UK-India Education and Research Initiative (UKIERI) Project Formulation Travel Grant to the Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Campus, London, UK – in 2006.
  • Good Teacher awarded by Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok, Sikkim, India – in 2004.
  • Fulbright Fellowship 2002 – 2003 under the Hubert H. Humphrey / National Institute on Drug Abuse (NIDA) Fellowship Program at Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA – August 2002 to June 2003.

Research Interest

  • Mental health – Epidemiology, prevention and treatment
  • Toxicology – Environmental neurotoxins


  • Number of Publications : 80

  1. Shrivastava A, Kumar A, Thomas JD, Laserson KF, Bhushan G, Carter MD, Chhabra M, Mittal V, Khare S, Sejvar JJ, Dwivedi M, Isenberg SL, Johnson R, Pirkle JL, Sharer JD, Hall PL, Yadav R, Velayudhan A, Papanna M, Singh P, Somashekar D, Pradhan A, Goel K, Pandey R, Kumar M, Kumar S, Chakrabarti A, Sivaperumal P, Kumar AR, Schier JG, Chang A, Graham LA, Mathews TP, Johnson D, Valentin L, Caldwell KL, Jarrett JM, Harden LA, Takeoka GR, Tong S, Queen K, Paden C, Whitney A, Haberling DL, Singh R, Singh RS, Earhart KC, Dhariwal AC, Chauhan LS, Venkatesh S, Srikantiah P. Association of acute toxic encephalopathy with litchi consumption in an outbreak in Muzaffarpur, India, 2014: a case-control study. Lancet Glob Health. 2017 ; Jan 30 : pii: S2214-109X(17)30035-9. doi: 10.1016/S2214-109X(17)30035-9.
  2. Goswami S, Dasgupta S, Samanta A, Talukdar G, Chanda A, Ray Karmakar P, Majumdar A, Bhattacharya D, Chakrabarti A. Load handling and repetitive movements are associated with chronic low back pain among jute mill workers in India. Pain Res Treat. 2016 ; 2016 : 7843216. doi:10.1155/2016/7843216.
  1. Hser YI, Liang D, Lan YC, Vicknasingam BK, Chakrabarti A. Drug Abuse, HIV, and HCV in Asian Countries. J Neuroimmune Pharmacol 2016 ; Online First. doi: 10.1007/s11481-016-9665-x.
  2. Shrivastava A, Srikantiah P, Kumar A, EIS India Cohort 1, EIS India Cohort 2, Chhabra M, Mittal V, Khare S, Sejvar J J, Dwivedi M, Laserson K, Earhart KC, Sivaperumal P, Ramesh Kumar A, Chakrabarti A, Thomas J, Schier J, Singh R, Singh RS, Dhariwal AC, Chauhan LS. Outbreaks of Unexplained Neurological Illness – Muzaffarpur, India, 2013 – 2014. Morbidity and Mortality Weekly Report (MMWR) 2015 ; 64 (3) : 49 – 53.
  1. Chakrabarti A, Rai TK, Sharma B, Rai BB. Culturally prevalent unrecorded alcohol consumption in Sikkim, North East India: Cross-sectional situation assessment. J Substance Use 2015 ; 20 (3) : 162 – 167. doi: 10.3109/14659891.2014.885598.
  2. Chakrabarti A, Rai TK, Sharma B, Rai BB. Correlates of problematic unrecorded alcohol consumption in Sikkim, North East India – Results from a cross sectional, pilot survey. Int Rev Psychiatry 2015 ; 27 (3) : 197 – 203. doi: 10.3109/09540261.2015.1019840.
  3. Ahongshangbam S, Chakrabarti A. Current analgesic use predicts low emotional quality of life in youth: A cross-sectional survey among university students in Sikkim, North East India. Indian J Med Res 2013 ; 137 : 1199 – 1203.
  1. Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD.  Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid dependent youth:  Secondary analyses from a NIDA Clinical Trials Network study.  Drug Alcohol Depend 2010 ; 107: 253 – 256.
  1. Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine–naloxone for opioid detoxification: Secondary analyses from the Clinical Trials Network. J Substance Abuse Treatment 2010 ; 38 Supplement 1 : S80 – S86.
  1. Goel A, Chakrabarti A. Prevalence and socio-demographic correlates of substance use in a rural community in Sikkim, North East India – Results from a pilot population survey. J Substance Use 2010 ; 15 : 13 – 23.